The 2024 Lasker~DeBakey Clinical Medical Research Award has honored three pioneering scientistsJoel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsenfor their groundbreaking contributions to the understanding and therapeutic application of glucagon-like peptide-1 (GLP-1) in the treatment of obesity
Data collection will run on a DNBSEQ-G400RS sequencer with DNBSEQ-G400RS High-throughput Sequencing Set (FCL PE150) (both MGI Tech Co., Shenzen, China)
disposition model, which were effects of body weight on clearance (CL), inter-compartment CL ( Q ), central volume ( V c ) and peripheral volume ( V p ), and effect of glycaemic status on CL
Lynch LA, OConnell JM, Kwasnik AK, Cawood TJ, OFarrelly C, OShea DB
Semaglutide and Digestive Health Semaglutides role in treating type 2 diabetes and obesity has been extensively studied, but its impact on digestive health, particularly concerning acid reflux, warrants a closer examination